BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 11560959)

  • 1. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
    Teh HS; Teh SJ
    Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4-Mediated inhibition of early events of T cell proliferation.
    Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
    J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell effector function and anergy avoidance are quantitatively linked to cell division.
    Wells AD; Walsh MC; Sankaran D; Turka LA
    J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 regulates induction of anergy in vivo.
    Greenwald RJ; Boussiotis VA; Lorsbach RB; Abbas AK; Sharpe AH
    Immunity; 2001 Feb; 14(2):145-55. PubMed ID: 11239447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
    Kubsch S; Graulich E; Knop J; Steinbrink K
    Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 ligation blocks CD28-dependent T cell activation.
    Walunas TL; Bakker CY; Bluestone JA
    J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
    Krummel MF; Allison JP
    J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
    Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
    J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness.
    Vanasek TL; Khoruts A; Zell T; Mueller DL
    J Immunol; 2001 Nov; 167(10):5636-44. PubMed ID: 11698435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells.
    Yi-qun Z; Lorré K; de Boer M; Ceuppens JL
    J Immunol; 1997 May; 158(10):4734-40. PubMed ID: 9144487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation requirements for the induction of CD4+CD25+ T cell suppressor function.
    Thornton AM; Piccirillo CA; Shevach EM
    Eur J Immunol; 2004 Feb; 34(2):366-76. PubMed ID: 14768041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.